{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,20]],"date-time":"2026-09-20T01:50:07Z","timestamp":1789869007749,"version":"4.0.1"},"reference-count":43,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,2,1]],"date-time":"2017-02-01T00:00:00Z","timestamp":1485907200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","atherosclerosis-journal.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Atherosclerosis"],"published-print":{"date-parts":[[2017,2]]},"DOI":"10.1016\/j.atherosclerosis.2017.01.015","type":"journal-article","created":{"date-parts":[[2017,1,16]],"date-time":"2017-01-16T16:19:29Z","timestamp":1484583569000},"page":"130-137","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":40,"special_numbering":"C","title":["Long-term outcome in 53 patients with homozygous familial hypercholesterolaemia in a single centre in France"],"prefix":"10.1016","volume":"257","author":[{"given":"Eric","family":"Bruckert","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olga","family":"Kalmykova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Randa","family":"Bittar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Val\u00e9rie","family":"Carreau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sophie","family":"B\u00e9liard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samir","family":"Saheb","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Rosenbaum","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dominique","family":"Bonnefont-Rousselot","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"Thomas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Corinne","family":"Emery","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Babak","family":"Khoshnood","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alain","family":"Carri\u00e9","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.atherosclerosis.2017.01.015_bib1","doi-asserted-by":"crossref","first-page":"2146","DOI":"10.1093\/eurheartj\/ehu274","volume":"35","author":"Cuchel","year":"2014","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.atherosclerosis.2017.01.015_bib2","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1016\/j.atherosclerosis.2012.02.019","article-title":"Homozygous familial hypercholesterolemia: current perspectives on diagnosis and treatment","volume":"223","author":"Raal","year":"2012","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.atherosclerosis.2017.01.015_bib3","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1136\/hrt.76.1.84","article-title":"Aortic stenosis in homozygous familial hypercholesterolaemia","volume":"76","author":"Rallidis","year":"1996","journal-title":"Heart"},{"key":"10.1016\/j.atherosclerosis.2017.01.015_bib4","doi-asserted-by":"crossref","first-page":"1438","DOI":"10.1016\/j.amjcard.2008.07.035","article-title":"Longitudinal evaluation and assessment of cardiovascular disease in patients with homozygous familial hypercholesterolemia","volume":"102","author":"Kolansky","year":"2008","journal-title":"Am. J. Cardiol."},{"key":"10.1016\/j.atherosclerosis.2017.01.015_bib5","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.jpeds.2010.06.027","article-title":"Sudden death in a 4-year-old boy: a near-complete occlusion of the coronary artery caused by an aggressive low-density lipoprotein receptor mutation (W556R) in homozygous familial hypercholesterolemia","volume":"158","author":"Widhalm","year":"2011","journal-title":"J.\u00a0Pediatr."},{"key":"10.1016\/j.atherosclerosis.2017.01.015_bib6","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1007\/8904_2011_45","article-title":"Fatal myocardial infarction at 4.5 years in a case of homozygous familial hypercholesterolaemia","volume":"2","author":"Gautschi","year":"2012","journal-title":"JIMD Rep."},{"key":"10.1016\/j.atherosclerosis.2017.01.015_bib7","doi-asserted-by":"crossref","first-page":"3478","DOI":"10.1093\/eurheartj\/eht273","volume":"34","author":"Nordestgaard","year":"2013","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.atherosclerosis.2017.01.015_bib8","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/j.jacl.2014.01.001","article-title":"Management of familial hypercholesterolemia in children and adolescents. Position paper of the Polish Lipid Expert Forum","volume":"8","author":"My\u015bliwiec","year":"2014","journal-title":"J.\u00a0Clin. Lipidol."},{"key":"10.1016\/j.atherosclerosis.2017.01.015_bib9","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/j.atherosclerosis.2015.09.021","article-title":"Familial hypercholesterolaemia: a global call to arms","volume":"243","author":"Vallejo-Vaz","year":"2015","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.atherosclerosis.2017.01.015_bib10","doi-asserted-by":"crossref","first-page":"2202","DOI":"10.1161\/CIRCULATIONAHA.111.042523","article-title":"Reduction in mortality in subjects with homozygous familial hypercholesterolemia associated with advances in lipid-lowering therapy","volume":"124","author":"Raal","year":"2011","journal-title":"Circulation"},{"key":"10.1016\/j.atherosclerosis.2017.01.015_bib11","author":"Human Genome Variation Society"},{"key":"10.1016\/j.atherosclerosis.2017.01.015_bib12","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1016\/S0026-0495(98)90352-3","article-title":"Hyperalphalipoproteinemia: characterization of a cardioprotective profile associating increased high-density lipoprotein2 levels and decreased hepatic lipase activity","volume":"47","author":"Didier","year":"1998","journal-title":"Metabolism"},{"key":"10.1016\/j.atherosclerosis.2017.01.015_bib13","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1093\/clinchem\/42.5.738","article-title":"Three routine methods for measuring high-density lipoprotein cholesterol compared with the reference method","volume":"42","author":"Harris","year":"1996","journal-title":"Clin. Chem."},{"key":"10.1016\/j.atherosclerosis.2017.01.015_bib14","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1093\/clinchem\/18.6.499","article-title":"Estimation of the concentration of LDL-cholesterol in plasma without use of preparative ultracentrifuge","volume":"18","author":"Friedewald","year":"1972","journal-title":"Clin. Chem."},{"key":"10.1016\/j.atherosclerosis.2017.01.015_bib15","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1016\/j.amjcard.2015.05.013","article-title":"Reliability of calculated low-density lipoprotein cholesterol","volume":"116","author":"Meeusen","year":"2015","journal-title":"Am. J. Cardiol."},{"key":"10.1016\/j.atherosclerosis.2017.01.015_bib16","first-page":"561","article-title":"Evaluation multicentrique sur diff\u00e9rents automates d\u2019analyses de trois m\u00e9thodes de dosage direct du cholest\u00e9rol-HDL","volume":"57","author":"Egloff","year":"1999","journal-title":"Ann. Biol. Clin."},{"key":"10.1016\/j.atherosclerosis.2017.01.015_bib17","first-page":"27","article-title":"Multicenter evaluation of four homogenous LDL-cholesterol assays","volume":"63","author":"Bayer","year":"2005","journal-title":"Ann. Biol. Clin."},{"key":"10.1016\/j.atherosclerosis.2017.01.015_bib18","doi-asserted-by":"crossref","first-page":"1801","DOI":"10.1097\/QAD.0b013e328357063c","article-title":"French National Agency for AIDS and Viral Hepatitis Research (ANRS) 126 study group. Effects of rosuvastatin versus pravastatin on low density lipoprotein diameter in HIV-1-infected patients receiving protease inhibitors","volume":"14","author":"Bittar","year":"2012","journal-title":"AIDS"},{"key":"10.1016\/j.atherosclerosis.2017.01.015_bib19","first-page":"2","article-title":"Commission de standardisation de l\u2019ARCOL. Recommandations pratiques pour le dosage du H-C apr\u00e8s pr\u00e9cipitation par le phosphotungstate de sodium et le chlorure de magnesium","volume":"49","author":"L\u00e9glise","year":"1996","journal-title":"Inf. Sci. Du. Biol."},{"key":"10.1016\/j.atherosclerosis.2017.01.015_bib20","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1016\/j.jacc.2006.09.043","article-title":"Value of low-density lipoprotein particle number and size as predictors of coronary artery disease in apparently healthy men and women: the EPIC-Norfolk Prospective Population Study","volume":"49","author":"El Harchaoui","year":"2007","journal-title":"J.\u00a0Am. Coll. Cardiol."},{"key":"10.1016\/j.atherosclerosis.2017.01.015_bib21","series-title":"Hierarchical Linear Models: Applications and Data Analysis Methods","author":"Raudenbush","year":"2002"},{"key":"10.1016\/j.atherosclerosis.2017.01.015_bib22","doi-asserted-by":"crossref","first-page":"964","DOI":"10.1093\/ije\/28.5.964","article-title":"The use of fractional polynomials to model continuous risk variables in epidemiology","volume":"28","author":"Royston","year":"1999","journal-title":"Int. J. Epidemiol."},{"key":"10.1016\/j.atherosclerosis.2017.01.015_bib23","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1016\/S0002-9149(97)89309-5","article-title":"Relation of cholesterol-year score to severity of calcific atherosclerosis and tissue deposition in homozygous familial hypercholesterolemia","volume":"77","author":"Schmidt","year":"1996","journal-title":"Am. J. Cardiol."},{"key":"10.1016\/j.atherosclerosis.2017.01.015_bib24","doi-asserted-by":"crossref","first-page":"267","DOI":"10.2165\/11591650-000000000-00000","article-title":"Long-term follow-up of statin treatment in a cohort of children with familial hypercholesterolemia: efficacy and tolerability","volume":"13","author":"Carreau","year":"2011","journal-title":"Paediatr. Drugs"},{"key":"10.1016\/j.atherosclerosis.2017.01.015_bib25","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1016\/j.atherosclerosis.2015.09.029","article-title":"Improved cardiovascular outcomes following temporal advances in lipid-lowering therapy in a genetically-characterised cohort of familial hypercholesterolaemia homozygotes","volume":"243","author":"Thompson","year":"2015","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.atherosclerosis.2017.01.015_bib26","doi-asserted-by":"crossref","first-page":"1303","DOI":"10.1016\/0140-6736(93)90815-X","article-title":"Mutations of low-density-lipoprotein-receptor gene, variation in plasma cholesterol, and expression of coronary heart disease in homozygous familial hypercholesterolaemia","volume":"341","author":"Moorjani","year":"1993","journal-title":"Lancet"},{"key":"10.1016\/j.atherosclerosis.2017.01.015_bib27","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1016\/j.atherosclerosis.2013.01.007","article-title":"Spectrum of mutations and phenotypic expression in patients with autosomal dominant hypercholesterolemia identified in Italy","volume":"227","author":"Bertolini","year":"2013","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.atherosclerosis.2017.01.015_bib28","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1016\/j.atherosclerosis.2005.11.016","article-title":"Autosomal recessive hypercholesterolemia (ARH) and homozygous familial hypercholesterolemia (FH): a phenotypic comparison","volume":"188","author":"Pisciotta","year":"2006","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.atherosclerosis.2017.01.015_bib29","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1016\/j.atherosclerosis.2015.01.007","article-title":"Impact of LDL apheresis on aortic root atheroma in children with homozygous familial hypercholesterolemia","volume":"239","author":"Lefort","year":"2015","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.atherosclerosis.2017.01.015_bib30","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1161\/ATVBAHA.107.160408","article-title":"Vascular calcifications in homozygote familial hypercholesterolemia","volume":"28","author":"Awan","year":"2008","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.atherosclerosis.2017.01.015_bib31","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/j.jacl.2012.03.004","article-title":"Apheresis in homozygous familial hypercholesterolemia: the results of a follow-up of all Norwegian patients with homozygous familial hypercholesterolemia","volume":"6","author":"Gr\u00e6sdal","year":"2012","journal-title":"J.\u00a0Clin. Lipidol."},{"key":"10.1016\/j.atherosclerosis.2017.01.015_bib32","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/S0140-6736(12)61731-0","article-title":"Phase 3 HoFH Lomitapide Study investigators. Efficacy and safety of a microsomal triglyceride transfer protein inhibitor in patients with homozygous familial hypercholesterolaemia: a single-arm, open-label, phase 3 study","volume":"381","author":"Cuchel","year":"2013","journal-title":"Lancet"},{"key":"10.1016\/j.atherosclerosis.2017.01.015_bib33","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.atherosclerosissup.2014.07.005","article-title":"Clinical experience of lomitapide therapy in patients with homozygous familial hypercholesterolaemia","volume":"15","author":"Cuchel","year":"2014","journal-title":"Atheroscler. Suppl."},{"key":"10.1016\/j.atherosclerosis.2017.01.015_bib34","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1016\/S0140-6736(10)60284-X","article-title":"Mipomersen, an apolipoprotein B synthesis inhibitor, for lowering of LDL cholesterol concentrations in patients with homozygous familial hypercholesterolaemia: a randomised, double-blind, placebo-controlled trial","volume":"375","author":"Raal","year":"2010","journal-title":"Lancet"},{"key":"10.1016\/j.atherosclerosis.2017.01.015_bib35","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1016\/S0140-6736(14)61374-X","article-title":"TESLA Investigators. Inhibition of PCSK9 with evolocumab in homozygous familial hypercholesterolaemia (TESLA Part B): a randomised, double-blind, placebo-controlled trial","volume":"385","author":"Raal","year":"2015","journal-title":"Lancet"},{"key":"10.1016\/j.atherosclerosis.2017.01.015_bib36","author":"Raal"},{"key":"10.1016\/j.atherosclerosis.2017.01.015_bib37","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1016\/j.atherosclerosis.2015.03.014","article-title":"Phase 3 HoFH Lomitapide Study Investigators. The lipid-lowering effects of lomitapide are unaffected by adjunctive apheresis in patients with homozygous familial hypercholesterolaemia - a post-hoc analysis of a Phase 3, single-arm, open-label trial","volume":"240","author":"Stefanutti","year":"2015","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.atherosclerosis.2017.01.015_bib38","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1016\/j.jacl.2016.02.018","article-title":"Pediatric experience with mipomersen as adjunctive therapy for homozygous familial hypercholesterolemia","volume":"10","author":"Raal","year":"2016","journal-title":"J.\u00a0Clin. Lipidol."},{"key":"10.1016\/j.atherosclerosis.2017.01.015_bib39","doi-asserted-by":"crossref","first-page":"1022","DOI":"10.1161\/CIRCULATIONAHA.113.001292","article-title":"Lomitapide and mipomersen. Two first-in-class drugs for reducing low-density lipoprotein cholesterol in patients with homozygous familial hypercholesterolemia","volume":"129","author":"Rader","year":"2014","journal-title":"Circulation"},{"key":"10.1016\/j.atherosclerosis.2017.01.015_bib40","doi-asserted-by":"crossref","first-page":"2796","DOI":"10.1200\/JCO.2009.25.0654","article-title":"Basic concepts and methods for joint models of longitudinal and survival data","volume":"28","author":"Ibrahim","year":"2010","journal-title":"J.\u00a0Clin. Oncol."},{"key":"10.1016\/j.atherosclerosis.2017.01.015_bib41","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1002\/pds.3607","article-title":"Using fractional polynomials to model the effect of cumulative duration of exposure on outcomes: applications to cohort and nested case-control designs","volume":"23","author":"Austin","year":"2014","journal-title":"Pharmacoepidemiol Drug Saf."},{"key":"10.1016\/j.atherosclerosis.2017.01.015_bib42","doi-asserted-by":"crossref","first-page":"2061","DOI":"10.1001\/jama.2013.280532","article-title":"Comparison of a novel method vs the Friedewald equation for estimating low-density lipoprotein cholesterol levels from the standard lipid profile","volume":"310","author":"Martin","year":"2013","journal-title":"JAMA"},{"key":"10.1016\/j.atherosclerosis.2017.01.015_bib43","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1093\/eurheartj\/ehu058","article-title":"Homozygous autosomal dominant hypercholesterolaemia in The Netherlands: prevalence, genotype-phenotype relationship, and clinical outcome","volume":"36","author":"Sjouke","year":"2015","journal-title":"Eur. Heart J."}],"container-title":["Atherosclerosis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0021915017300175?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0021915017300175?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,7,21]],"date-time":"2022-07-21T17:25:28Z","timestamp":1658424328000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0021915017300175"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,2]]},"references-count":43,"alternative-id":["S0021915017300175"],"URL":"https:\/\/doi.org\/10.1016\/j.atherosclerosis.2017.01.015","relation":{},"ISSN":["0021-9150"],"issn-type":[{"value":"0021-9150","type":"print"}],"subject":[],"published":{"date-parts":[[2017,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Long-term outcome in 53 patients with homozygous familial hypercholesterolaemia in a single centre in France","name":"articletitle","label":"Article Title"},{"value":"Atherosclerosis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.atherosclerosis.2017.01.015","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}